Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sigma Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $31.05 billion
P/E Ratio 43.39
Dividend Yield 1.49%
Shares Outstanding 11.50 billion
Earnings per share 0.062
Dividend per share 0.04
Year To Date Return -7.14%
Earnings Yield 2.30%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Sigma Healthcare Ltd (ASX: SIG)
    Latest News

    Woman looking at data on her laptop.
    Growth Shares

    3 ASX 200 shares I would buy and hold for 10 years

    These three businesses have the sort of growth runways I want for a 10-year investment.

    Read more »

    Businesswoman with a pleased smile reading on her laptop at a desk in the office with a look of satisfaction.
    ASX Share Market News

    5 things to watch on the ASX 200 on Tuesday

    It looks set to be a good session for Aussie investors.

    Read more »

    A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.
    Healthcare Shares

    Sigma Healthcare vs Sonic Healthcare: Which ASX healthcare share wins?

    I compare Sigma Healthcare and Sonic Healthcare to reveal which ASX healthcare share I think is the better buy right…

    Read more »

    Six smiling health workers pose for a selfie.
    ASX Share Market News

    ASX 200 healthcare shares lead a weaker market amid 82% chance of a rate hike

    Healthcare shares gained 3.76% while the ASX 200 fell 0.11% last week.

    Read more »

    Couple holding a piggy bank, symbolising superannuation.
    Retirement

    3 ASX shares I'd buy for income and growth in retirement

    I take a closer look at three shares I would consider owning throughout retirement.

    Read more »

    Six smiling office colleagues stand in a row and look at the camera.
    Broker Notes

    9 ASX 200 shares earning strengthened buy ratings this week

    Brokers retained a positive view on Santos, Goodman, AMP, Telstra, and other shares this week. 

    Read more »

    Hands reaching high for a trophy with a sunset in the background.
    Healthcare Shares

    A rare buying opportunity in 1 of Australia's top shares?

    This business is generating very healthy profit growth.

    Read more »

    Happy businessman fist pumping while looking at a tablet.
    Broker Notes

    2 ASX shares tipped to return 19% to 47%

    Recent sell-offs have caught Morgans’ attention, with the broker now rating both shares as buys.

    Read more »

    a woman in a business suit looks wide eyed and interested as she holds a tin can with string to hear ear listening to some news.
    Broker Notes

    UBS names its 10 top ASX picks for the next 3-6 months

    Here are the 10 ASX shares UBS thinks could outperform.

    Read more »

    Woman and man at work looking at data on a tablet at work.
    Dividend Investing

    Own BHP, Woodside or Coles shares? Here's what investors should know

    Some big-name shares could distort the market today.

    Read more »

    Numerous Australian dollar notes laid out.
    Investing Strategies

    Where I'd invest $20,000 in ASX shares this spring

    I like the long-term growth opportunities sitting in front of each of these businesses.

    Read more »

    Man smiling ahead while working on his MacBook.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    03 Sep 2026 $0.0200 100.00% Interim 22 Sep 2026
    04 Mar 2026 $0.0200 100.00% Final 20 Mar 2026
    02 Sep 2025 $0.0130 100.00% Interim 18 Sep 2025
    01 Oct 2024 $0.0050 0.00% Interim 17 Oct 2024
    28 Mar 2024 $0.0050 50.00% Final 17 Apr 2024
    25 Sep 2023 $0.0050 100.00% Interim 11 Oct 2023
    30 Mar 2023 $0.0050 100.00% Final 18 Apr 2023
    29 Sep 2022 $0.0050 100.00% Interim 12 Oct 2022
    04 Apr 2022 $0.0100 100.00% Final 22 Apr 2022
    24 Sep 2021 $0.0100 100.00% Interim 08 Oct 2021
    06 Apr 2021 $0.0100 100.00% Final 21 Apr 2021
    19 Sep 2019 $0.0100 100.00% Interim 04 Oct 2019
    03 Apr 2019 $0.0200 100.00% Final 29 Apr 2019
    12 Oct 2018 $0.0150 100.00% Interim 29 Oct 2018
    05 Apr 2018 $0.0250 100.00% Final 20 Apr 2018
    19 Sep 2017 $0.0250 100.00% Interim 05 Oct 2017
    06 Apr 2017 $0.0300 100.00% Final 21 Apr 2017
    20 Sep 2016 $0.0250 100.00% Interim 03 Oct 2016
    06 Apr 2016 $0.0300 100.00% Final 21 Apr 2016
    03 Apr 2014 $0.0200 100.00% Final 30 Apr 2014
    21 Sep 2012 $0.0200 100.00% Interim 26 Oct 2012
    05 Apr 2011 $0.1500 100.00% Special Cash 11 May 2011
    16 Oct 2009 $0.0300 100.00% Interim 13 Nov 2009
    31 Mar 2009 $0.0400 100.00% Final 07 May 2009
    30 Sep 2008 $0.0300 100.00% Interim 29 Oct 2008
    29 Aug 2005 $0.0200 100.00% Interim 15 Sep 2005
    02 Mar 2004 $0.2000 100.00% Final 23 Mar 2004

    SIG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Sigma Healthcare Ltd

    Sigma Healthcare Ltd (ASX: SIG) is an Australian pharmaceutical wholesaler and retail pharmacy franchisor. Following its 2025 merger with Chemist Warehouse, Sigma now combines wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies with a large retail network operating under brands including Chemist Warehouse, Amcal, Discount Drug Stores, and My Chemist.

    The company also provides dose administration aid services and technology and data analytics solutions to its pharmacy customers. Sigma Healthcare was founded in 1912 and is headquartered in Clayton, Victoria.

    SIG Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    09 Oct 2026 $2.69 $0.07 2.67% 11,437,917 $2.63 $2.70 $2.62
    08 Oct 2026 $2.62 $-0.02 -0.76% 15,788,824 $2.64 $2.65 $2.59
    07 Oct 2026 $2.64 $0.02 0.76% 25,698,950 $2.63 $2.66 $2.63
    06 Oct 2026 $2.62 $0.02 0.77% 10,797,547 $2.62 $2.64 $2.60
    05 Oct 2026 $2.60 $0.00 0.00% 8,842,625 $2.60 $2.63 $2.59
    02 Oct 2026 $2.60 $0.03 1.17% 9,569,267 $2.58 $2.60 $2.57
    01 Oct 2026 $2.57 $-0.02 -0.77% 15,688,512 $2.58 $2.59 $2.55
    30 Sep 2026 $2.59 $0.03 1.17% 16,571,012 $2.56 $2.60 $2.55
    29 Sep 2026 $2.56 $0.00 0.00% 7,738,692 $2.56 $2.58 $2.54
    28 Sep 2026 $2.56 $-0.01 -0.39% 14,228,539 $2.55 $2.57 $2.55
    25 Sep 2026 $2.57 $-0.01 -0.39% 12,264,109 $2.58 $2.59 $2.56
    24 Sep 2026 $2.58 $0.02 0.78% 14,858,018 $2.53 $2.60 $2.53
    23 Sep 2026 $2.56 $0.00 0.00% 12,444,941 $2.57 $2.58 $2.55
    22 Sep 2026 $2.56 $0.03 1.19% 9,949,887 $2.51 $2.57 $2.51
    21 Sep 2026 $2.53 $-0.02 -0.78% 9,543,132 $2.54 $2.56 $2.52
    18 Sep 2026 $2.55 $0.05 2.00% 40,248,099 $2.50 $2.55 $2.47
    17 Sep 2026 $2.50 $-0.09 -3.47% 33,594,477 $2.59 $2.62 $2.50
    16 Sep 2026 $2.59 $-0.05 -1.89% 31,743,068 $2.64 $2.65 $2.59
    15 Sep 2026 $2.64 $0.01 0.38% 22,782,545 $2.63 $2.65 $2.62
    14 Sep 2026 $2.63 $0.00 0.00% 24,475,593 $2.62 $2.65 $2.61
    11 Sep 2026 $2.63 $-0.01 -0.38% 18,156,490 $2.63 $2.64 $2.62
    10 Sep 2026 $2.64 $-0.03 -1.12% 24,863,126 $2.65 $2.66 $2.64

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    18 Sep 2026 Mario Verrocchi Buy 2,000,000 $5,092,146
    On-market trade.
    14 Sep 2026 Neville Mitchell Buy 20,000 $53,100
    On-market trade.
    31 Aug 2026 Vikesh Ramsunder Issued 564,896 $1,519,570
    Issue of securities. 2,389,068 rights and performance shares
    09 Jan 2026 Vikesh Ramsunder Issued 813,449 $2,350,867
    Issue of securities. 1824172 Rights
    09 Jan 2026 Danielle Di Pilla Issued 141,591 $409,197
    Issue of securities. 141,591 2025 LTI Rights
    09 Jan 2026 Mario Verrocchi Issued 314,021 $907,520
    Issue of securities. 314,021 2025 LTI Rights
    10 Nov 2025 Annette Carey Buy 10,000 $31,237
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Oct 2023
    Dr Roberts is the Chair of the Risk, Compliance and Sustainability Committee. He has more than 40 years' experience in the medical device industry, including as the Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a director of ResMed Inc until November 2017. Dr Roberts is currently a Non-Executive Director of Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. Dr Roberts is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
    Mr Neville Mitchell Non-Executive Director Feb 2023
    Mr Mitchell is member of the IBC Committee. Mr Mitchell has financial experience coupled with board experience as a Non-Executive Director. He is currently a Non-Executive Director of Sonic Healthcare Limited from September 2017. He is Chair of the Sonic Audit Committee. He has international healthcare and finance experience. Prior to becoming a Non-Executive Director, he had a career spanning 27 years with Cochlear Limited and 22 years as Chief Financial Officer and Company Secretary.
    Mr Michael Sammells Non-Executive DirectorNon-Executive Chairman Feb 2020
    Mr Sammells is also the Chair of the Related Party Independent Board Committee (IBC). He is currently a Non-Executive Director at AMP Limited and a director at GMHBA. He has over 35 years of experience in finance, corporate services and has held operational roles with experience in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. He is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
    Mr Vikesh Ramsunder Chief Executive OfficerManaging Director Feb 2022
    Mr Ramsunder brings blend of operational leadership, strategic focus, industry and financial acumen. He has experience in wholesaling, logistics, pharmacy and retailing, and was integral to the growth of the Clicks Group which is now one of the pharmacy and retail operations in Africa. Prior to joining Sigma, Mr Ramsunder spent 28 years with the Clicks Group, including 18 years as a member of the executive team. Mr Ramsunder served as Group CEO from January 2019 to December 2021 and previously held senior leadership positions including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesaler business, United Pharmaceutical Distributors from 2010.
    Ms Annette May Carey Non-Executive Director Apr 2023
    Ms Carey is member of the IBC and Member of the Risk, Compliance and Sustainability Committee. She is a current Non-Executive Director of Downer EDI Limited, Bapcor Limited and the Kinetic bus group. She was a previous Non-Executive Director of National Intermodal Corporation. She previously held legal roles at two commercial law firms and the Lendlease group before joining Linfox Logistics and progressing from General Counsel and Company Secretary to Chief Executive Officer of Linfox Logistics ANZ and Linfox Armaguard. She also held the position of Executive General Manager International with Australia Post. She has held director roles within the Linfox group of companies and been Chair or Deputy Chair of Australia Post joint ventures in the UK and China. She has a balance of technical experience as well as legal, strategic and commercial intellect from over 30 years' experience in supply chain, logistics, cross border e-commerce and commercial law.
    Mr Jack Gance Non-Executive Director Feb 2025
    Mr Gance is member of the Risk, Compliance and Sustainability Committee. He co-founded Chemist Warehouse with Mr S Gance. He was previously Chair of Chemist Warehouse. He opened his first pharmacy store in Reservoir, Victoria, with Mr S Gance in 1972. In 1997, Messrs Gance and Mr Verrocchi, established MyChemist and opened the first MyChemist store. In 2000, they established the Chemist Warehouse chain and opened the first Chemist Warehouse store. Mr Gance also created the brands Le Specs, Le Tan and Colours of Australis.
    Ms Danielle Di Pilla Executive Director Feb 2025
    Ms Di Pilla is a Member of the Risk, Compliance and Sustainability Committee. She established DPP Pharmaceuticals Pty Ltd (DPP) in 2000 and is the founder of brands such as Goat Soap, which has had international success. Ms Di Pilla is the Managing Director of DPP since it was incorporated. She also currently sits on the Board of Gotcha4Life.
    Mr Mario Verrocchi Executive Director Feb 2025
    Mr Verrocchi is a Member of the Risk, Compliance and Sustainability Committee. He is also the Chief Executive Officer - Retail. He joined Mr J Gance and Mr S Gance's pharmacy group in 1982. He established MyChemist with Messrs Gance in 1997 and subsequently created the Chemist Warehouse chain with Messrs Gance in 2000.
    Mr Damien Gance Executive Director Feb 2025
    Mr Gance is a Member of the Risk, Compliance and Sustainability Committee. He joined MyChemist in 1998 and was the first Chemist Warehouse Franchisee opening the first Chemist Warehouse pharmacy in June 2000. He was previously the Chief Strategy and Business Development Officer of the Group.
    Ms Kara McGowan General Counsel Chief Legal OfficerCompany Secretary Oct 2021
    -
    Kara McGowan General Counsel Chief Legal OfficerCompany Secretary
    -
    Richard Murray CFO
    -
    Gary Woodford Other Executive Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mfv Family Foundation Pty Ltd 2,233,512,925 19.35%
    HSBC Custody Nominees (Australia) Limited 1,568,948,429 13.59%
    Jeg Family Foundation Pty Ltd 1,395,930,781 12.09%
    Sg Family Foundation Pty Ltd 1,301,217,384 11.27%
    Citicorp Nominees Pty Limited 1,124,032,765 9.74%
    J P Morgan Nominees Australia Pty Limited 726,155,579 6.29%
    Mjv Family Foundation Pty Ltd 280,000,000 2.43%
    Av Family Foundation Pty Ltd 275,524,439 2.39%
    BNP Paribas Noms Pty Ltd 156,027,444 1.35%
    Mr Sunil Narula 155,893,114 1.35%
    Dgsr Family Foundation Pty Ltd 127,329,615 1.10%
    BNP Paribas Nominees Pty Ltd 92,318,155 0.80%
    Rispin Mott Nominees Pty Ltd 67,615,674 0.59%
    NMS Nominees Pty Ltd 65,065,709 0.56%
    NMS Nominees Pty Ltd i 55,986,218 0.48%
    Citicorp Nominees Pty Limited i 53,100,179 0.46%
    Mat Family Foundation Pty Ltd 48,144,781 0.42%
    Invia Custodian Pty Limited 47,500,000 0.41%
    UBS Nominees Pty Ltd 47,229,447 0.41%
    Netwealth Investments Limited 42,696,069 0.37%

    Profile

    since

    Note